skip to main content

    Updated Visitor Guidelines

 

MENU

 

Why Young Men Need to Get the HPV Vaccine

Oropharyngeal cancer, which occurs in the throat, tonsils, and back of the tongue, has now surpassed cervical cancer as the leading cancer caused by HPV — and 80% of those diagnosed with it are men.

Rogel Cancer Center joins top cancer centers in call to get cancer-preventing HPV vaccination back on track

National Cancer Institute-designated cancer centers and leading cancer organizations issued a joint statement urging the nation’s physicians, parents and young adults to get back on track with the human papillomavirus, or HPV, vaccination.

Ovarian Cancer Patients Continue to Receive Aggressive End of Life Care

Although clinical guidelines encourage the use of palliative care during end of life care, they aren't being followed for many ovarian cancer patients, particularly for people of color. Palliative care is particularly relevant for people with ovarian cancer because they’re often diagnosed once their cancer has already progressed to an advanced stage. By that point, survival is unlikely; just 17% of those with stage IV ovarian cancer live for at least five years after diagnosis.

HPV Behind Increase In Head and Neck Cancers in Taiwan, Study Finds

The findings suggest policies and public health interventions in Taiwan could help prevent HPV-driven cancers.

New UPSeq Test Holds Promise for Detecting Aggressive Prostate Cancer

The Urine Prostate Seq test, or UPSeq for short, uses next-generation genomic sequencing to analyze urine collected from men following a digital rectal exam.

Biomarker Could Help Identify MiTF Renal Cell Carcinoma

High expression levels of the gene TRIM63 can serve as an accurate and sensitive biomarker of a subtype of kidney cancer known as microphthalmia-associated transcription factor family aberration-associated renal cell carcinomas — or MiTF renal cell carcinoma.

Pembrolizumab Benefits Patients with Metastatic Breast Cancer and High Mutational Burden

The immunotherapy agent pembrolizumab can provide clinical benefit to some patients with metastatic breast cancer whose tumors were found to have a high number of mutations, and whose cancer continued to progress with standard treatments.

Women Should Screen for Both Colorectal and Cervical Cancer

This research emphasizes the harms of making colorectal cancer screening independent from cervical cancer screening instead of linking them together as part of important preventative care.

Pages